Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03158688 |
|---|---|
| Brief Title: | Study of Carfilzomib, Daratumumab and Dexamethasone for Patients With Relapsed and/or Refractory Multiple Myeloma. (CANDOR) |
| First Submitted : | May 9, 2017 |
| First Submitted that Met QC Criteria : | May 16, 2017 |
| First Posted : | May 18, 2017 |
| Results First Submitted : | July 13, 2020 |
| Results First Posted with QC Comments : | August 6, 2020 |
| Results First Submitted that Met QC Criteria : | August 21, 2020 |
| Results First Posted : | September 11, 2020 |
| Last Update Submitted that Met QC Criteria : | March 1, 2024 |
| Last Update Posted : | March 5, 2024 |